As outlined by ACR guidelines, allopurinol is strongly advised as a primary-line urate-lowering medication. Genetic screening is usually recommended (to get a variant named HLA B*5801) before starting off allopurinol since the carriers of this gene are at an elevated hazard of a extreme allergic rea